PatrickM.LynchMD
Gastroenterology • Houston, TXAssociate Professor of Medicine, University Tex Houston
Are you Dr. Lynch?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Patrick Lynch, MD is a gastroenterologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center and is an Associate Professor of Medicine at University Tex Houston.
Education & Training
Baylor College of MedicineFellowship, Gastroenterology, 1986 - 1988
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1983 - 1986
Creighton University School of MedicineClass of 1983
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1988 - 2025
OK State Medical License 2020 - 2021
AR State Medical License 1984 - 1992- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis Start of enrollment: 2002 Nov 21
- The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) Start of enrollment: 1994 Sep 01
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsIn Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation.Ester Borras, Kyle Chang, Mala Pande, Amanda Cuddy, Jennifer L. Bosch
Cancer Prevention Research. 2017-10-01 - 97 citationsNCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.Jennifer M. Weiss, Samir Gupta, Carol A. Burke, Lisen Axell, Lee-may Chen
Journal of the National Comprehensive Cancer Network. 2021-10-15 - 40 citationsDelphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.Giulia Martina Cavestro, Alessandro Mannucci, Francesc Balaguer, Heather Hampel, Sonia S Kupfer
Clinical Gastroenterology and Hepatology. 2023-03-01
Grant Support
- Phase II Clinical Trial Of Celecoxib In Persons With GEDivision Of Cancer Prevention And Control2000
- Phase II Multiple-Dose Safety &Efficacy Study Of A SELEDivision Of Cancer Prevention And Control1997–1999
- Calcium Modulation Of Colon Cancer Intermediate MarkersNational Cancer Institute1989
